Show results for
Refine by
Zanidatamab Medical Equipment & Supplies In In Eritrea
1 equipment items found
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as a best-in-class treatment for patients with HER2-expressing cancers, including biliary tract, gastroesophageal adenocarcinomas, breast, and other ...